DRDR.L vs. BTEC.L
DRDR.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) and BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) are both Health & Biotech Equities funds from iShares - DRDR.L tracks the MSCI World/Health Care NR USD while BTEC.L tracks the NASDAQ Biotechnology NET Index. Both are passively managed. Over the past 5 years, DRDR.L returned -0.78%/yr vs 6.09%/yr for BTEC.L. Their correlation of 0.81 suggests significant overlap in exposure. DRDR.L charges 0.40%/yr vs 0.35%/yr for BTEC.L.
Performance
DRDR.L vs. BTEC.L - Performance Comparison
Loading charts...
Different Trading Currencies
DRDR.L is traded in GBp, while BTEC.L is traded in USD. To make them comparable, the BTEC.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, DRDR.L achieves a 6.68% return, which is significantly lower than BTEC.L's 13.97% return.
DRDR.L
- 1D
- -0.17%
- 1M
- 6.96%
- 6M
- 2.11%
- YTD
- 6.68%
- 1Y
- 25.03%
- 3Y*
- 7.44%
- 5Y*
- -0.78%
- 10Y*
- —
BTEC.L
- 1D
- 0.00%
- 1M
- 7.86%
- 6M
- 11.73%
- YTD
- 13.97%
- 1Y
- 47.71%
- 3Y*
- 15.40%
- 5Y*
- 6.09%
- 10Y*
- —
DRDR.L vs. BTEC.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 6.68% | 10.25% | 2.62% | -2.51% | -14.93% | -5.21% | 48.69% | 8.88% | 2.12% | 3.70% |
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 13.97% | 23.49% | -0.33% | 0.91% | -1.44% | 0.45% | 23.66% | 20.79% | -5.96% | -5.88% |
Correlation
The correlation between DRDR.L and BTEC.L is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.81 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2017 | 0.81 |
The correlation between DRDR.L and BTEC.L has been stable across timeframes, ranging from 0.81 to 0.82 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRDR.L vs. BTEC.L — Risk / Return Rank
DRDR.L
BTEC.L
DRDR.L vs. BTEC.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DRDR.L | BTEC.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.74 | ||
| Sortino ratioReturn per unit of downside risk | -0.84 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.37 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 1.99 | 6.45 | -4.46 |
| Martin ratioReturn relative to average drawdown | 4.87 | 18.57 | -13.70 |
Loading charts...
Drawdowns
DRDR.L vs. BTEC.L - Drawdown Comparison
The maximum DRDR.L drawdown since its inception was -38.49%, which is greater than BTEC.L's maximum drawdown of -31.02%. Use the drawdown chart below to compare losses from any high point for DRDR.L and BTEC.L.
Loading charts...
Drawdown Indicators
| DRDR.L | BTEC.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.49% | -31.02% | -7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -12.51% | -7.31% | -5.20% |
Max Drawdown (3Y)Largest decline over 3 years | -22.88% | -26.37% | +3.49% |
Max Drawdown (5Y)Largest decline over 5 years | -35.81% | -31.02% | -4.79% |
Current DrawdownCurrent decline from peak | -12.21% | -5.72% | -6.49% |
Average DrawdownAverage peak-to-trough decline | -17.39% | -9.99% | -7.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.13% | 2.54% | +2.59% |
Volatility
DRDR.L vs. BTEC.L - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) is 5.03%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) has a volatility of 5.91%. This indicates that DRDR.L experiences smaller price fluctuations and is considered to be less risky than BTEC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRDR.L | BTEC.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.03% | 5.91% | -0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 11.99% | 15.31% | -3.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.94% | 20.42% | -4.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.14% | 20.98% | +1.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.54% | 22.30% | +0.24% |
DRDR.L vs. BTEC.L - Expense Ratio Comparison
DRDR.L has a 0.40% expense ratio, which is higher than BTEC.L's 0.35% expense ratio.
Dividends
DRDR.L vs. BTEC.L - Dividend Comparison
Neither DRDR.L nor BTEC.L has paid dividends to shareholders.
Frequently Asked Questions
DRDR.L and BTEC.L have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEC.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEC.L is cheaper with a 0.35% expense ratio, compared with 0.40% for DRDR.L.
DRDR.L tracks MSCI World/Health Care NR USD, while BTEC.L tracks NASDAQ Biotechnology NET Index. Their fees differ too: 0.40% for DRDR.L and 0.35% for BTEC.L.
Find the right allocation for DRDR.L and BTEC.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer